BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 15273491)

  • 1. New strategies for cervical cancer screening in adolescents.
    Gray SH; Walzer TB
    Curr Opin Pediatr; 2004 Aug; 16(4):344-9. PubMed ID: 15273491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer.
    Ogilvie GS; Krajden M; van Niekerk D; Smith LW; Cook D; Ceballos K; Lee M; Gentile L; Gondara L; Elwood-Martin R; Peacock S; Stuart G; Franco EL; Coldman AJ
    Int J Cancer; 2017 Jan; 140(2):440-448. PubMed ID: 27685757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of genital human papillomavirus infection in a female adolescent population.
    Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
    Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening by cytology and human papillomavirus testing during pregnancy in French women with poor adhesion to regular cervical screening.
    Brun-Micaleff E; Coffy A; Rey V; Didelot MN; Combecal J; Doutre S; Daurès JP; Segondy M; Boulle N
    J Med Virol; 2014 Mar; 86(3):536-45. PubMed ID: 24114972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
    Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The health and economic effects of HPV DNA screening in The Netherlands.
    Berkhof J; Coupé VM; Bogaards JA; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ
    Int J Cancer; 2010 Nov; 127(9):2147-58. PubMed ID: 20112339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of multiple primary and combination screening strategies in postmenopausal women for detection of cervical cancer in China.
    Holt HK; Zhang L; Zhao FH; Hu SY; Zhao XL; Zhang X; Pan QJ; Zhang WH; Smith JS; Qiao YL
    Int J Cancer; 2017 Feb; 140(3):544-554. PubMed ID: 27727464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing self- and provider-collected swabbing for HPV DNA testing in female-to-male transgender adult patients: a mixed-methods biobehavioral study protocol.
    Reisner SL; Deutsch MB; Peitzmeier SM; White Hughto JM; Cavanaugh T; Pardee DJ; McLean S; Marrow EJ; Mimiaga MJ; Panther L; Gelman M; Green J; Potter J
    BMC Infect Dis; 2017 Jun; 17(1):444. PubMed ID: 28645254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.
    Arbyn M; Sasieni P; Meijer CJ; Clavel C; Koliopoulos G; Dillner J
    Vaccine; 2006 Aug; 24 Suppl 3():S3/78-89. PubMed ID: 16950021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACOG Committee Opinion No. 463: Cervical cancer in adolescents: screening, evaluation, and management.
    Obstet Gynecol; 2010 Aug; 116(2 Pt 1):469-472. PubMed ID: 20664421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer screening.
    Wiley DJ; Monk BJ; Masongsong E; Morgan K
    Curr Oncol Rep; 2004 Nov; 6(6):497-506. PubMed ID: 15485621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACOG Practice Bulletin no. 109: Cervical cytology screening.
    Obstet Gynecol; 2009 Dec; 114(6):1409-1420. PubMed ID: 20134296
    [No Abstract]   [Full Text] [Related]  

  • 16. Cervical screening in England and Wales: an update.
    Mohan S; Ind T
    Curr Opin Obstet Gynecol; 2004 Dec; 16(6):491-6. PubMed ID: 15534446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is it reality or an illusion that liquid-based cytology is better than conventional cervical smears? Authors' reply.
    Herbert A; Johnson J
    Cytopathology; 2002 Apr; 13(2):133. PubMed ID: 11952753
    [No Abstract]   [Full Text] [Related]  

  • 18. Is it reality or an illusion that liquid-based cytology is better than conventional cervical smears?
    Moseley R
    Cytopathology; 2002 Apr; 13(2):135-6. PubMed ID: 11952756
    [No Abstract]   [Full Text] [Related]  

  • 19. Human papillomavirus infection in adolescents: a rational approach.
    Bartholomew DA
    Adolesc Med Clin; 2004 Oct; 15(3):569-95. PubMed ID: 15625994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid-based cytology for cervical screening.
    Payne N; Chilcott J; McGoogan E
    Cytopathology; 2000 Dec; 11(6):469-70. PubMed ID: 11194077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.